Your browser doesn't support javascript.
loading
How to Stimulate and Facilitate Early Stage Antibiotic Discovery.
Zuegg, Johannes; Hansford, Karl A; Elliott, Alysha G; Cooper, Matthew A; Blaskovich, Mark A T.
Afiliação
  • Zuegg J; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072 Australia.
  • Hansford KA; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072 Australia.
  • Elliott AG; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072 Australia.
  • Cooper MA; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072 Australia.
  • Blaskovich MAT; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072 Australia.
ACS Infect Dis ; 6(6): 1302-1304, 2020 06 12.
Article em En | MEDLINE | ID: mdl-32527097
ABSTRACT
The discovery of novel antibiotics is essential to combat the rise of antimicrobial resistance. While a number of initiatives are focused on advancing promising leads into the clinic, there is a dearth of effort at stimulating the early stage discovery. We present one pathway that has successfully demonstrated an ability to revitalize fundamental research and reengage researchers.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antibacterianos Idioma: En Revista: ACS Infect Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antibacterianos Idioma: En Revista: ACS Infect Dis Ano de publicação: 2020 Tipo de documento: Article